Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diphtheria”

360 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 360 results

Large-scale testing (Phase 3)Study completedNCT01353703
What this trial is testing

Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine

Who this might be right for
PoliomyelitisTetanusAcellular Pertussis+4 more
GlaxoSmithKline 224
Large-scale testing (Phase 3)Study completedNCT00453570
What this trial is testing

Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months

Who this might be right for
DiphtheriaTetanusHaemophilus Influenzae Type b+2 more
Sanofi 792
Large-scale testing (Phase 3)Study completedNCT01341639
What this trial is testing

Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)

Who this might be right for
Bacterial InfectionsVirus Diseases
MCM Vaccines B.V. 1,250
Post-approval studies (Phase 4)UnknownNCT04056728
What this trial is testing

A Phase IV Study to Assess the Safety of EupentaTM Inj

Who this might be right for
Hepatitis BDiphtheriaHaemophilus Influenzae Type B Infection+2 more
LG Chem 3,000
Large-scale testing (Phase 3)Study completedNCT01917357
What this trial is testing

A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and Uniject

Who this might be right for
DiphtheriaPertussisTetanus+2 more
Crucell Holland BV 400
Post-approval studies (Phase 4)Study completedNCT01270503
What this trial is testing

Post-Marketing Safety Study of Menactra® in Healthy Children, Adolescents, and Adults in the Philippines

Who this might be right for
MeningitisMeningococcal Disease
Sanofi Pasteur, a Sanofi Company 538
Post-approval studies (Phase 4)UnknownNCT00877357
What this trial is testing

Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Shantha Biotechnics Limited 3,000
Not applicableStudy completedNCT02757950
What this trial is testing

A Post-marketing, Observational, Retrospective Study to Assess the Safety of RefortrixTM (Tdap) When Administered During Pregnancy in a Maternal Immunization Program in Brazil.

Who this might be right for
Diphtheria
GlaxoSmithKline 2,462
Testing effectiveness (Phase 2)Study completedNCT01061541
What this trial is testing

Immunogenicity, Safety & Reactogenicity of GSK Vaccine Tritanrix™-HepB/Hib2.5 Compared to GSK Vaccine Tritanrix™-HepB/Hiberix™

Who this might be right for
Haemophilus Influenzae Type b
GlaxoSmithKline 192
Not applicableStudy completedNCT03950986
What this trial is testing

Increasing Vaccine Uptake Among Veterans at the Atlanta VA Health Care System

Who this might be right for
InfluenzaTetanusDiphtheria+2 more
Atlanta VA Medical Center 67,000
Not applicableStudy completedNCT00297856
What this trial is testing

Post-marketing Safety Study of GSK Biologicals' Boostrix® Vaccine

Who this might be right for
DiphtheriaTetanusAcellular Pertussis
GlaxoSmithKline 10,000
Early research (Phase 1)Looking for participantsNCT06184542
What this trial is testing

Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine

Who this might be right for
DiphtheriaTetanusPertussis
Institute of Medical Biology, Chinese Academy of Medical Sciences 460
Large-scale testing (Phase 3)Study completedNCT01309646
What this trial is testing

Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib Vaccine

Who this might be right for
PoliomyelitisTetanusAcellular Pertussis+2 more
GlaxoSmithKline 454
Large-scale testing (Phase 3)Study completedNCT01642589
What this trial is testing

Safety and Immunogenicity Study for Use of Menactra® Versus Adacel® in Subjects 11 to 55 Years of Age in South Korea

Who this might be right for
MeningitisMeningococcal Disease
Sanofi Pasteur, a Sanofi Company 300
Not applicableUnknownNCT06605755
What this trial is testing

Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants

Who this might be right for
PertussisDiphtheriaTetanus+2 more
Jiangsu Province Centers for Disease Control and Prevention 785
Early research (Phase 1)Study completedNCT02382913
What this trial is testing

Persistency Study After aP / Tdap Booster Vaccines in Adult Subjects (V113_01 Extension 1)

Who this might be right for
Pertussis
Novartis 315
Early research (Phase 1)Study completedNCT01482052
What this trial is testing

Safety Study of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine for Meningitis

Who this might be right for
Meningococcal MeningitisMeningococcal Infections
JN-International Medical Corporation 60
Post-approval studies (Phase 4)Study completedNCT00514059
What this trial is testing

Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio Vaccine

Who this might be right for
DiphtheriaTetanusPertussis+1 more
Norwegian Institute of Public Health 83
Large-scale testing (Phase 3)Study completedNCT00352963
What this trial is testing

Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age).

Who this might be right for
PoliomyelitisTetanusAcellular Pertussis+2 more
GlaxoSmithKline 480
Testing effectiveness (Phase 2)Study completedNCT04071158
What this trial is testing

A RSV VACCINE WHEN GIVEN TOGETHER WITH TDAP IN HEALTHY NONPREGNANT WOMEN AGED BETWEEN 18 TO 49 YEARS

Who this might be right for
Respiratory Tract Infection
Pfizer 713
Next Page